SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Receptos,Inc. (RCPT)
An SI Board Since November 2014
Posts SubjectMarks Bans Symbol
9 4 0 PRCT
Emcee:  Miljenko Zuanic Type:  Moderated
Introduction Market Data Compact
Have no idea did someone brought this company to participants attentions, so if did my apologize for duplicating tread. Seams as very interesting and promising bios, but with extremely (current) high valuation. Wish that I did learn about them year ago.

Miljenko
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9I was short on/off for last 3-4 months, and I was shorty yesterday (small positMiljenko Zuanic-7/15/2015
8Sure hope you got stopped out already on this trade! Cheers, Tucktuck-7/15/2015
7Receptos MS Drug Succeeds Against Ulcerative Colitis news.investors.comJulius Wong-4/17/2015
6CC was, more or less, waste of time. No clear explanation (safety?, efficacy plaMiljenko Zuanic-2/24/2015
5Nothing new here (yet, until Monday), is 16% v 6% clinical remission at W12 signMiljenko Zuanic-2/18/2015
4Yup! Have nothing against company, but some valuation are out of any reasonable Miljenko Zuanic-12/3/2014
3$126-130 I assume :)rkrw-12/2/2014
2Just to make it clear, I am short stock from 226-230. Big chunk!Miljenko Zuanic112/2/2014
1Successful expected secondary, next is partner for RPC1063, is this drug for reaMiljenko Zuanic-11/20/2014
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News